Disc Medicine, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−0.69%
vs ±8.5% implied · ×0.08
shaded = implied · ▲▼ = realized
No thesis.
Disc Medicine, Inc.
82.73
−0.11 · −0.13%
post 80.77 −2.37%
Fund move
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | FMRFMR | $358.0M | 11.32% | −12.39% | |
| 2 | BlackRockBlackRockindex-like | $180.5M | 5.71% | +8.53% | |
| 3 | RA Capital ManagementRA Capital Management | $179.2M | 5.67% | 0.00% | |
| 4 | JPMorgan ChaseJPMorgan Chase | $139.9M | 4.42% | +36.77% | |
| 5 | T. Rowe Price AssociatesT. Rowe Price | $137.2M | 4.34% | +21.04% | |
| 6 | Wellington Management GroupWellington | $127.4M | 4.03% | +0.34% | |
| 7 | State StreetState Streetindex-like | $120.6M | 3.81% | −2.91% | |
| 8 | Vestal Point CapitalVestal Point Capital | $113.4M | 3.59% | +121.43% | |
| 9 | Atlas Venture Life Science AdvisorsAtlas Venture Life Science | $110.7M | 3.50% | 0.00% | |
| 10 | Vanguard Capital ManagementVanguardindex-like | $100.1M | 3.17% | −0.47% | |
| 11 | Frazier Life Sciences ManagementFrazier Life Sciences | $99.1M | 3.13% | 0.00% | |
| 12 | TCG Crossover ManagementTCG Crossover | $98.1M | 3.10% | 0.00% | |
| 13 | BVFBVF | $84.4M | 2.67% | −9.33% | |
| 14 | Woodline PartnersWoodline Partners | $70.1M | 2.22% | 0.00% | |
| 15 | SirenSiren | $65.0M | 2.06% | −10.12% | |
| 16 | Logos Global ManagementLogos Global | $64.0M | 2.02% | +56.25% | |
| 17 | Opaleye ManagementOpaleye | $62.5M | 1.98% | +103.09% | |
| 18 | Geode Capital ManagementGeodeindex-like | $57.8M | 1.83% | +6.11% | |
| 19 | Deerfield ManagementDeerfield | $48.1M | 1.52% | 0.00% | |
| 20 | Dimensional Fund AdvisorsDimensional | $41.6M | 1.32% | +44.26% | |
| 21 | Bellevue GroupBellevue | $41.0M | 1.30% | +21.92% | |
| 22 | Saturn V Capital ManagementSaturn V | $38.4M | 1.21% | +16.63% | |
| 23 | Armistice CapitalArmistice Capital | $33.6M | 1.06% | −14.18% | |
| 24 | Jennison AssociatesJennison | $32.1M | 1.02% | −27.99% | |
| 25 | Standard Life AberdeenStandard Life Aberdeen | $32.0M | 1.01% | +16.66% |
221 managers report $3.2B of Disc Medicine on form 13F for the quarter ended Jun 30 '26. 29 of them hold 80% of it; FMR is largest at 11.32%.
Linked news
Expected move
Inputsspot 80.84exp Mar 19ATM strike 80ATM straddle 18.85IV 48%